drugset
drugset / Trial / NCT01819922

Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

NCT01819922 ↗

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverDouble-blindBasic science

Summary

This study is designed to assess the effect of one single dose of PF-05175157 on metabolic and cardiopulmonary parameters before, during and after treadmill exercise in healthy volunteers.

Timeline

Start
2013-04
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05175157 Small molecule 600 mg Oral

Indications

No indication recorded.